Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction

被引:96
作者
Alberry, Medhat S. [1 ,5 ]
Maddocks, Deborah G. [3 ]
Hadi, Medhat A. [5 ]
Metawi, Helmi [5 ]
Hunt, Linda P. [4 ]
Abdel-Fattah, Sherif A. [1 ]
Avent, Neil D. [3 ]
Soothill, Peter W. [2 ]
机构
[1] Univ Bristol, Dept Fetal Med, St Michaels Hosp, Bristol, Avon, England
[2] Univ Bristol, Dept Obstet & Gynecol, St Michaels Hosp, Bristol, Avon, England
[3] Univ W England, Ctr Biomed Res, Fac Sci Appl, Bristol BS16 1QY, Avon, England
[4] Univ Bristol S Bristol, Inst Child Life & Hlth, Dept Clin Sci, Bristol, Avon, England
[5] Ain Shams Univ, Dept Obstet & Gynecol, Matern Hosp, Cairo, Egypt
关键词
fetal DNA; fetal growth restriction; normal pregnancy; preeclampsia; QUANTITATIVE PCR MEASUREMENT; DOPPLER WAVE-FORM; GROWTH RESTRICTION; PRENATAL DETECTION; NORMAL RANGES; SERUM; PREECLAMPSIA; WOMEN; ULTRASOUND; ELEVATION;
D O I
10.1016/j.ajog.2008.07.063
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To assess the normal levels of free fetal DNA in maternal plasma through pregnancy compared with those in pregnancies complicated with placental dysfunction manifested by preeclampsia and/or fetal growth restriction. STUDY DESIGN: Maternal blood samples from 138 singleton male pregnancies were divided into 3 groups; normal pregnancies (77), preeclampsia (49), and fetal growth restriction (12). Royston and Wright's methods were used to calculate gestational age-related reference limits of free fetal DNA in the 3 groups. The DYS14 gene of the Y chromosome was quantified and compared in maternal plasma by using real-time quantitative polymerase chain reaction. RESULTS: Free fetal DNA in normal pregnancies increased with gestational age. Results were significantly higher in preeclampsia and fetal growth restriction groups than in normal pregnancy and were higher in severe preeclampsia than in milder disease. CONCLUSION: Free fetal DNA is a potential marker for placental dysfunction in pregnancy. Large prospective studies are now needed to investigate its role in the prediction of pregnancy complications and severity and or timing of delivery.
引用
收藏
页码:98.e1 / 98.e6
页数:6
相关论文
共 30 条
  • [1] Management of fetal growth restriction
    Alberry, M.
    Soothill, P.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2007, 92 (01): : F62 - F67
  • [2] Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast
    Alberry, M.
    Maddocks, D.
    Jones, M.
    Hadi, M. Abdel
    Abdel-Fattah, S.
    Avent, N.
    Soothill, P. W.
    [J]. PRENATAL DIAGNOSIS, 2007, 27 (05) : 415 - 418
  • [3] Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound
    Bobrow, CS
    Holmes, RP
    Muttukrishna, S
    Mohan, A
    Groome, N
    Murphy, DJ
    Soothill, PW
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (02) : 283 - 287
  • [4] Fetal growth velocity: a cautionary tale
    Bobrow, CS
    Soothill, PW
    [J]. LANCET, 1999, 353 (9163) : 1460 - 1460
  • [5] Cell-free fetal DNA concentration in plasma of patients with abnormal uterine artery Doppler waveform and intrauterine growth restriction - a pilot study
    Caramelli, E
    Rizzo, N
    Concu, M
    Simonazzi, G
    Carinci, P
    Bondavalli, C
    Bovicelli, L
    Farina, A
    [J]. PRENATAL DIAGNOSIS, 2003, 23 (05) : 367 - 371
  • [6] CHANG TC, 1993, OBSTET GYNECOL, V82, P230
  • [7] Prenatal exclusion of β thalassaemia major by examination of maternal plasma
    Chiu, RWK
    Lau, TK
    Leung, TN
    Chow, KCK
    Chui, DHK
    Lo, YMD
    [J]. LANCET, 2002, 360 (9338) : 998 - 1000
  • [8] ECLAMPSIA IN THE UNITED-KINGDOM
    DOUGLAS, KA
    REDMAN, CWG
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 309 (6966): : 1395 - 1400
  • [9] Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial
    Duley, L
    Farrell, B
    Spark, P
    Roberts, B
    Watkins, K
    Bricker, L
    Wang, L
    Armstrong, N
    Tivnin, M
    Salih, N
    Hurst, A
    Smyth, R
    Cooper, S
    Wilson, A
    Bowler, U
    Notman, J
    [J]. LANCET, 2002, 359 (9321) : 1877 - 1890
  • [10] Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy
    Farina, A
    LeShane, ES
    Lambert-Messerlian, GM
    Canick, JA
    Lee, T
    Neveux, LM
    Palomaki, GE
    Bianchi, DW
    [J]. CLINICAL CHEMISTRY, 2003, 49 (02) : 239 - 242